Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial (Q34682814)

3 August 2017

title

Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial (English)

1 reference

3 August 2017

0 references

0 references

1 reference

Nicholas A Di Prospero

1 reference

3 August 2017

Angela Baker

1 reference

3 August 2017

Neal Jeffries

1 reference

3 August 2017

Kenneth H Fischbeck

1 reference

3 August 2017

publication date

1 October 2007

1 reference

3 August 2017

1 reference

inferred from page(s)

published in

Lancet Neurology

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

878-886

1 reference

Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Clinical and genetic abnormalities in patients with Friedreich's ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Increased levels of plasma malondialdehyde in Friedreich ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Oxidative stress in patients with Friedreich ataxia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Friedreich's ataxia: idebenone treatment in early stage patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Safety, Tolerability, and Pharmacokinetics of High-Dose Idebenone in Patients With Friedreich Ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Chemical determination of free radical-induced damage to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Glutathione in blood of patients with Friedreich's ataxia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Role of oxidative damage in Friedreich's ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Chemistry, toxicology, pharmacology and pharmacokinetics of idebenone: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970220-X

7 January 2021

10.1016/S1474-4422(07)70220-X

Identifiers

DOI

1 reference

3 August 2017

1 reference